Huntington National Bank’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27 | Hold |
1
| – | – | ﹤0.01% | 3310 |
|
|
2025
Q4 | $27 | Hold |
1
| – | – | ﹤0.01% | 3223 |
|
|
2025
Q3 | $27 | Hold |
1
| – | – | ﹤0.01% | 3276 |
|
|
2025
Q2 | $27 | Hold |
1
| – | – | ﹤0.01% | 3300 |
|
|
2025
Q1 | $27 | Hold |
1
| – | – | ﹤0.01% | 3323 |
|
|
2024
Q4 | $27 | Hold |
1
| – | – | ﹤0.01% | 3348 |
|
|
2024
Q3 | $27 | Hold |
1
| – | – | ﹤0.01% | 3338 |
|
|
2024
Q2 | $27 | Hold |
1
| – | – | ﹤0.01% | 3289 |
|
|
2024
Q1 | $27 | Hold |
1
| – | – | ﹤0.01% | 3145 |
|
|
2023
Q4 | $27 | Hold |
1
| – | – | ﹤0.01% | 3051 |
|
|
2023
Q3 | $27 | Hold |
1
| – | – | ﹤0.01% | 3027 |
|
|
2023
Q2 | $27 | Hold |
1
| – | – | ﹤0.01% | 2998 |
|
|
2023
Q1 | $27 | Hold |
1
| – | – | ﹤0.01% | 2846 |
|
|
2022
Q4 | $27 | Hold |
1
| – | – | ﹤0.01% | 2713 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 2511 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2519 |
|
|
2022
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2457 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | +$19 | ﹤0.01% | 2389 |
|
Huntington National Bank's MYOV Position: Q1 2026 in Review
Huntington National Bank held its Myovant Sciences Ltd. (MYOV) position steady in Q1 2026 at 1 share worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #3310.
Huntington National Bank first reported a position in MYOV in Q4 2021 and has held it in 18 quarters since. 1 fund tracked by Wall St. Rank holds MYOV as of Q1 2026.
- Huntington National Bank held 1 share of Myovant Sciences Ltd. worth $27 as of Q1 2026.
- Huntington National Bank left its Myovant Sciences Ltd. share count unchanged in Q1 2026.
- Myovant Sciences Ltd. made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #3310 holding.
- Huntington National Bank first reported a position in Myovant Sciences Ltd. in Q4 2021 and has held it in 18 quarters since.
- 1 fund tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2026.
Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.